CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Regenxbio Inc.  (RGNX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Regenxbio's Quick Ratio

RGNX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

RGNX Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change 90.17 % 259.67 % 35.23 % 1.28 % -
Y / Y Cash & cash equivalent Change 72.05 % 44.29 % -21.54 % -56.99 % -
Quick Ratio MRQ 41.05 35.31 58.04 17.07 45.38
Overall Ranking # 47 # 74 # 77 # 0 #
Seq. Current Liabilities Change -4.38 % 167.6 % -71.3 % 158.96 % 80.84 %
Seq. Cash & cash equivalent Change 11.16 % 62.82 % -2.41 % -2.59 % -6.78 %



Quick Ratio second quarter 2017 Comment
Regenxbio's Cash & cash equivalent grew by 11.16 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Regenxbio's Quick Ratio to 41.05, Quick Ratio remained below Regenxbio Inc. average.

Within Biotechnology & Drugs industry 4 other companies have achieved higher Quick Ratio than Regenxbio in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are RGNX Segments?
See Quick Ratio RGNX on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 5
Healthcare Sector # 10
Overall Market # 47


Quick Ratio Statistics
High Average Low
100.04 53.14 17.07
(Dec 31 2015)   (Sep 30 2016)


You need to upgrade your Flash Player


Financial Statements
Regenxbio's Current Liabilities $ 4 Millions Visit RGNX's Balance sheet
Regenxbio's Cash & cash equivalent $ 162 Millions Visit RGNX's Balance sheet
Source of RGNX's Sales Visit RGNX's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Biotechnology & Drugs Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Adverum Biotechnologies, Inc.  63.95 $ 197.418  Millions$ 3.087  Millions
Protokinetix, Inc.  44.13 $ 0.238  Millions$ 0.005  Millions
Regenxbio Inc.  41.05 $ 162.083  Millions$ 3.948  Millions
Enzon Pharmaceuticals, Inc.  23.01 $ 11.206  Millions$ 0.487  Millions
Aerie Pharmaceuticals Inc  22.30 $ 307.919  Millions$ 13.810  Millions
Neurocrine Biosciences Inc  18.94 $ 525.020  Millions$ 27.721  Millions
Atara Biotherapeutics, Inc.  18.91 $ 217.090  Millions$ 11.481  Millions
Gtx Inc  18.83 $ 11.356  Millions$ 0.603  Millions
Fennec Pharmaceuticals Inc.  17.64 $ 10.232  Millions$ 0.580  Millions
Anavex Life Sciences Corp.  17.27 $ 24.793  Millions$ 1.436  Millions
Crispr Therapeutics Ag  17.22 $ 272.264  Millions$ 15.814  Millions
La Jolla Pharmaceutical Co  17.09 $ 141.317  Millions$ 8.271  Millions
Microbot Medical Inc.  17.03 $ 13.078  Millions$ 0.768  Millions
Organovo Holdings, Inc.  14.91 $ 54.974  Millions$ 3.688  Millions
Bluebird Bio, Inc.  14.07 $ 1,095.434  Millions$ 77.838  Millions
Obalon Therapeutics Inc  13.13 $ 60.725  Millions$ 4.625  Millions
Asterias Biotherapeutics, Inc.  12.39 $ 25.016  Millions$ 2.019  Millions
Tracon Pharmaceuticals, Inc.  12.10 $ 31.998  Millions$ 2.644  Millions
Adaptimmune Therapeutics Plc  11.97 $ 202.021  Millions$ 16.881  Millions
Voyager Therapeutics, Inc.  11.94 $ 141.323  Millions$ 11.836  Millions
Syndax Pharmaceuticals Inc  11.30 $ 130.056  Millions$ 11.505  Millions
Fulgent Genetics, Inc.  10.61 $ 28.873  Millions$ 2.722  Millions
Idera Pharmaceuticals, Inc.  10.51 $ 77.235  Millions$ 7.351  Millions
Lixte Biotechnology Holdings, Inc.  10.11 $ 2.032  Millions$ 0.201  Millions
Acceleron Pharma Inc  10.04 $ 143.553  Millions$ 14.299  Millions
Audentes Therapeutics, Inc.  9.82 $ 145.828  Millions$ 14.855  Millions
Brainstorm Cell Therapeutics Inc.  9.45 $ 6.717  Millions$ 0.711  Millions
Edge Therapeutics, Inc.  9.38 $ 108.715  Millions$ 11.591  Millions
Intellia Therapeutics, Inc.  9.14 $ 241.047  Millions$ 26.371  Millions
Compugen Ltd  9.10 $ 46.111  Millions$ 5.067  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
TNLX's Profile
Stock Price
TNLX's Financials
TNLX's Expectations
Business Description
Fundamentals
Charts & Quotes
TNLX's News
Suppliers
TNLX's Competitors
Customers & Markets
Economic Indicators
TNLX's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com